Biomaterials for sequestration of growth factors and modulation of cell behavior
Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments....
Gespeichert in:
Veröffentlicht in: | Advanced functional materials 2020-10, Vol.30 (44), p.n/a |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 44 |
container_start_page | |
container_title | Advanced functional materials |
container_volume | 30 |
creator | Teixeira, Simão P. B. Domingues, Rui Miguel Andrade Shevchuk, Mariya Gomes, Manuela E. Peppas, Nicholas A. Reis, R. L. |
description | Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments. Biomaterialâ based approaches are increasingly sought as alternatives to improve the efficacy or, ideally, replace the need for exogenous administration of GFs in regenerative medicine strategies. The means by which these systems evolve from biomaterials for conventional controlled release of GFs to the recent extracellular matrix (ECM)â inspired approaches for sequestering these labile molecules and regulating their spatiotemporal activity and presentation are reviewed. Focus is placed on biomaterials functionalized either with ECM components, which show promiscuous GF binding, or with targeted GF ligands (antibodies, aptamers, or peptides). The potential of synthetic platforms with abiotic affinity as costâ effective alternatives to the current biological ligands is also discussed. Overall, the various GF sequestering systems developed so far have remarkably improved the activity of GFs at reduced doses and, in some cases, completely avoided the need for their exogenous administration to guide cell fates. These bioinspired concepts thus enable the rational exploration of the full therapeutic potential of GFs in regenerative medicine.
The authors acknowledge the financial support from project NORTE-01- 0145-FEDER-000021 supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the European Union Framework Programme for Research and Innovation HORIZON 2020, under the TEAMING Grant Agreement No 739572 — The Discoveries CTR EU, Twinning Grant agreement No 810850 — Achilles, European Research Council Grant Agreement No 772817; FCT/MCTES (Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia, e Ensino Superior), and the Fundo Social Europeu através do Programa Operacional do Capital Humano (FSE/POCH) in the framework of Ph.D. Grant PD/169/2013–PD/BD/143039/2018 for S.P.B.T., and project Grant PTDC/NAN-MAT/30595/2017. |
doi_str_mv | 10.1002/adfm.201909011 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2454584902</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2454584902</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4191-6bac5db8d330fae56bf0438ec44a41c42841434d6b82f681917f69d19ffeeb9d3</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EEqWwMltiTvE5jmuP5aOAVAQDSGyW4w-aKqmLnbbqvyclqGJjuhue573Ti9AlkBEQQq-19c2IEpBEEoAjNAAOPMsJFceHHT5O0VlKC0JgPM7ZAL3eVKHRrYuVrhP2IeLkvtYutVG3VVji4PFnDNt2jr02bYgJ66XFTbDr-gAYV9e4dHO9qUI8Rye-i3IXv3OI3qf3b7eP2ezl4el2MssMAwkZL7UpbClsnhOvXcFLT1gunGFMMzCMCgYsZ5aXgnouOmXsubQgvXeulDYfoqs-dxXDz8NqEdZx2Z1UlBWsEEwS2lGjnjIxpBSdV6tYNTruFBC1b03tW1OH1jpB9sK2qt3uH1pN7qbPf13cu9FovVLRbarU6qRAUKo4K7p_vgHQGXwn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2454584902</pqid></control><display><type>article</type><title>Biomaterials for sequestration of growth factors and modulation of cell behavior</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Teixeira, Simão P. B. ; Domingues, Rui Miguel Andrade ; Shevchuk, Mariya ; Gomes, Manuela E. ; Peppas, Nicholas A. ; Reis, R. L.</creator><creatorcontrib>Teixeira, Simão P. B. ; Domingues, Rui Miguel Andrade ; Shevchuk, Mariya ; Gomes, Manuela E. ; Peppas, Nicholas A. ; Reis, R. L.</creatorcontrib><description>Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments. Biomaterialâ based approaches are increasingly sought as alternatives to improve the efficacy or, ideally, replace the need for exogenous administration of GFs in regenerative medicine strategies. The means by which these systems evolve from biomaterials for conventional controlled release of GFs to the recent extracellular matrix (ECM)â inspired approaches for sequestering these labile molecules and regulating their spatiotemporal activity and presentation are reviewed. Focus is placed on biomaterials functionalized either with ECM components, which show promiscuous GF binding, or with targeted GF ligands (antibodies, aptamers, or peptides). The potential of synthetic platforms with abiotic affinity as costâ effective alternatives to the current biological ligands is also discussed. Overall, the various GF sequestering systems developed so far have remarkably improved the activity of GFs at reduced doses and, in some cases, completely avoided the need for their exogenous administration to guide cell fates. These bioinspired concepts thus enable the rational exploration of the full therapeutic potential of GFs in regenerative medicine.
The authors acknowledge the financial support from project NORTE-01- 0145-FEDER-000021 supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the European Union Framework Programme for Research and Innovation HORIZON 2020, under the TEAMING Grant Agreement No 739572 — The Discoveries CTR EU, Twinning Grant agreement No 810850 — Achilles, European Research Council Grant Agreement No 772817; FCT/MCTES (Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia, e Ensino Superior), and the Fundo Social Europeu através do Programa Operacional do Capital Humano (FSE/POCH) in the framework of Ph.D. Grant PD/169/2013–PD/BD/143039/2018 for S.P.B.T., and project Grant PTDC/NAN-MAT/30595/2017.</description><identifier>ISSN: 1616-301X</identifier><identifier>EISSN: 1616-3028</identifier><identifier>DOI: 10.1002/adfm.201909011</identifier><language>eng</language><publisher>Hoboken: Wiley-VCH Verlag</publisher><subject>Affinity binding ; Antibodies ; Biological activity ; Biomaterials ; Biomedical materials ; Chemical compounds ; Controlled release ; Growth factors ; Ligands ; Materials science ; Molecular recognition ; Peptides ; Pharmacology ; Science & Technology ; Sequestering ; Stem cells</subject><ispartof>Advanced functional materials, 2020-10, Vol.30 (44), p.n/a</ispartof><rights>2020 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim</rights><rights>2020 Wiley‐VCH GmbH</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4191-6bac5db8d330fae56bf0438ec44a41c42841434d6b82f681917f69d19ffeeb9d3</citedby><cites>FETCH-LOGICAL-c4191-6bac5db8d330fae56bf0438ec44a41c42841434d6b82f681917f69d19ffeeb9d3</cites><orcidid>0000-0002-3654-9906 ; 0000-0002-2036-6291 ; 0000-0003-2764-4319</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fadfm.201909011$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fadfm.201909011$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids></links><search><creatorcontrib>Teixeira, Simão P. B.</creatorcontrib><creatorcontrib>Domingues, Rui Miguel Andrade</creatorcontrib><creatorcontrib>Shevchuk, Mariya</creatorcontrib><creatorcontrib>Gomes, Manuela E.</creatorcontrib><creatorcontrib>Peppas, Nicholas A.</creatorcontrib><creatorcontrib>Reis, R. L.</creatorcontrib><title>Biomaterials for sequestration of growth factors and modulation of cell behavior</title><title>Advanced functional materials</title><description>Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments. Biomaterialâ based approaches are increasingly sought as alternatives to improve the efficacy or, ideally, replace the need for exogenous administration of GFs in regenerative medicine strategies. The means by which these systems evolve from biomaterials for conventional controlled release of GFs to the recent extracellular matrix (ECM)â inspired approaches for sequestering these labile molecules and regulating their spatiotemporal activity and presentation are reviewed. Focus is placed on biomaterials functionalized either with ECM components, which show promiscuous GF binding, or with targeted GF ligands (antibodies, aptamers, or peptides). The potential of synthetic platforms with abiotic affinity as costâ effective alternatives to the current biological ligands is also discussed. Overall, the various GF sequestering systems developed so far have remarkably improved the activity of GFs at reduced doses and, in some cases, completely avoided the need for their exogenous administration to guide cell fates. These bioinspired concepts thus enable the rational exploration of the full therapeutic potential of GFs in regenerative medicine.
The authors acknowledge the financial support from project NORTE-01- 0145-FEDER-000021 supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the European Union Framework Programme for Research and Innovation HORIZON 2020, under the TEAMING Grant Agreement No 739572 — The Discoveries CTR EU, Twinning Grant agreement No 810850 — Achilles, European Research Council Grant Agreement No 772817; FCT/MCTES (Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia, e Ensino Superior), and the Fundo Social Europeu através do Programa Operacional do Capital Humano (FSE/POCH) in the framework of Ph.D. Grant PD/169/2013–PD/BD/143039/2018 for S.P.B.T., and project Grant PTDC/NAN-MAT/30595/2017.</description><subject>Affinity binding</subject><subject>Antibodies</subject><subject>Biological activity</subject><subject>Biomaterials</subject><subject>Biomedical materials</subject><subject>Chemical compounds</subject><subject>Controlled release</subject><subject>Growth factors</subject><subject>Ligands</subject><subject>Materials science</subject><subject>Molecular recognition</subject><subject>Peptides</subject><subject>Pharmacology</subject><subject>Science & Technology</subject><subject>Sequestering</subject><subject>Stem cells</subject><issn>1616-301X</issn><issn>1616-3028</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNqFkD1PwzAQhi0EEqWwMltiTvE5jmuP5aOAVAQDSGyW4w-aKqmLnbbqvyclqGJjuhue573Ti9AlkBEQQq-19c2IEpBEEoAjNAAOPMsJFceHHT5O0VlKC0JgPM7ZAL3eVKHRrYuVrhP2IeLkvtYutVG3VVji4PFnDNt2jr02bYgJ66XFTbDr-gAYV9e4dHO9qUI8Rye-i3IXv3OI3qf3b7eP2ezl4el2MssMAwkZL7UpbClsnhOvXcFLT1gunGFMMzCMCgYsZ5aXgnouOmXsubQgvXeulDYfoqs-dxXDz8NqEdZx2Z1UlBWsEEwS2lGjnjIxpBSdV6tYNTruFBC1b03tW1OH1jpB9sK2qt3uH1pN7qbPf13cu9FovVLRbarU6qRAUKo4K7p_vgHQGXwn</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Teixeira, Simão P. B.</creator><creator>Domingues, Rui Miguel Andrade</creator><creator>Shevchuk, Mariya</creator><creator>Gomes, Manuela E.</creator><creator>Peppas, Nicholas A.</creator><creator>Reis, R. L.</creator><general>Wiley-VCH Verlag</general><general>Wiley Subscription Services, Inc</general><scope>RCLKO</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SP</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>L7M</scope><orcidid>https://orcid.org/0000-0002-3654-9906</orcidid><orcidid>https://orcid.org/0000-0002-2036-6291</orcidid><orcidid>https://orcid.org/0000-0003-2764-4319</orcidid></search><sort><creationdate>20201001</creationdate><title>Biomaterials for sequestration of growth factors and modulation of cell behavior</title><author>Teixeira, Simão P. B. ; Domingues, Rui Miguel Andrade ; Shevchuk, Mariya ; Gomes, Manuela E. ; Peppas, Nicholas A. ; Reis, R. L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4191-6bac5db8d330fae56bf0438ec44a41c42841434d6b82f681917f69d19ffeeb9d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Affinity binding</topic><topic>Antibodies</topic><topic>Biological activity</topic><topic>Biomaterials</topic><topic>Biomedical materials</topic><topic>Chemical compounds</topic><topic>Controlled release</topic><topic>Growth factors</topic><topic>Ligands</topic><topic>Materials science</topic><topic>Molecular recognition</topic><topic>Peptides</topic><topic>Pharmacology</topic><topic>Science & Technology</topic><topic>Sequestering</topic><topic>Stem cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teixeira, Simão P. B.</creatorcontrib><creatorcontrib>Domingues, Rui Miguel Andrade</creatorcontrib><creatorcontrib>Shevchuk, Mariya</creatorcontrib><creatorcontrib>Gomes, Manuela E.</creatorcontrib><creatorcontrib>Peppas, Nicholas A.</creatorcontrib><creatorcontrib>Reis, R. L.</creatorcontrib><collection>RCAAP open access repository</collection><collection>CrossRef</collection><collection>Electronics & Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Advanced functional materials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teixeira, Simão P. B.</au><au>Domingues, Rui Miguel Andrade</au><au>Shevchuk, Mariya</au><au>Gomes, Manuela E.</au><au>Peppas, Nicholas A.</au><au>Reis, R. L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomaterials for sequestration of growth factors and modulation of cell behavior</atitle><jtitle>Advanced functional materials</jtitle><date>2020-10-01</date><risdate>2020</risdate><volume>30</volume><issue>44</issue><epage>n/a</epage><issn>1616-301X</issn><eissn>1616-3028</eissn><abstract>Growth factors (GFs) are proteins secreted by cells that regulate a variety of biological processes. Although they have long been proposed as potent therapeutic agents, their administration in a soluble form has proven costly and ineffective due to their short halfâ lives in biological environments. Biomaterialâ based approaches are increasingly sought as alternatives to improve the efficacy or, ideally, replace the need for exogenous administration of GFs in regenerative medicine strategies. The means by which these systems evolve from biomaterials for conventional controlled release of GFs to the recent extracellular matrix (ECM)â inspired approaches for sequestering these labile molecules and regulating their spatiotemporal activity and presentation are reviewed. Focus is placed on biomaterials functionalized either with ECM components, which show promiscuous GF binding, or with targeted GF ligands (antibodies, aptamers, or peptides). The potential of synthetic platforms with abiotic affinity as costâ effective alternatives to the current biological ligands is also discussed. Overall, the various GF sequestering systems developed so far have remarkably improved the activity of GFs at reduced doses and, in some cases, completely avoided the need for their exogenous administration to guide cell fates. These bioinspired concepts thus enable the rational exploration of the full therapeutic potential of GFs in regenerative medicine.
The authors acknowledge the financial support from project NORTE-01- 0145-FEDER-000021 supported by Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); the European Union Framework Programme for Research and Innovation HORIZON 2020, under the TEAMING Grant Agreement No 739572 — The Discoveries CTR EU, Twinning Grant agreement No 810850 — Achilles, European Research Council Grant Agreement No 772817; FCT/MCTES (Fundação para a Ciência e a Tecnologia/ Ministério da Ciência, Tecnologia, e Ensino Superior), and the Fundo Social Europeu através do Programa Operacional do Capital Humano (FSE/POCH) in the framework of Ph.D. Grant PD/169/2013–PD/BD/143039/2018 for S.P.B.T., and project Grant PTDC/NAN-MAT/30595/2017.</abstract><cop>Hoboken</cop><pub>Wiley-VCH Verlag</pub><doi>10.1002/adfm.201909011</doi><tpages>26</tpages><orcidid>https://orcid.org/0000-0002-3654-9906</orcidid><orcidid>https://orcid.org/0000-0002-2036-6291</orcidid><orcidid>https://orcid.org/0000-0003-2764-4319</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1616-301X |
ispartof | Advanced functional materials, 2020-10, Vol.30 (44), p.n/a |
issn | 1616-301X 1616-3028 |
language | eng |
recordid | cdi_proquest_journals_2454584902 |
source | Wiley Online Library Journals Frontfile Complete |
subjects | Affinity binding Antibodies Biological activity Biomaterials Biomedical materials Chemical compounds Controlled release Growth factors Ligands Materials science Molecular recognition Peptides Pharmacology Science & Technology Sequestering Stem cells |
title | Biomaterials for sequestration of growth factors and modulation of cell behavior |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T11%3A49%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomaterials%20for%20sequestration%20of%20growth%20factors%20and%20modulation%20of%20cell%20behavior&rft.jtitle=Advanced%20functional%20materials&rft.au=Teixeira,%20Sim%C3%A3o%20P.%20B.&rft.date=2020-10-01&rft.volume=30&rft.issue=44&rft.epage=n/a&rft.issn=1616-301X&rft.eissn=1616-3028&rft_id=info:doi/10.1002/adfm.201909011&rft_dat=%3Cproquest_cross%3E2454584902%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2454584902&rft_id=info:pmid/&rfr_iscdi=true |